+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Achelios Therapeutics - logo

Achelios Therapeutics is a biopharmaceutical company that reformulates non-steroidal anti-inflammatory drug molecules for the treatment of pain and inflammation. Its best known products are TOPOFEN, a product for the indication of acute migraine, prophylactic migraine, osteoarthritis, and sprains and strains; and ACHETOGEL, a gel-based formulation that enables transdermal penetration of active ingredients to the target tissue. The company was founded in 2012 and is based in Chapel Hill, North Carolina.

Osteoarthritis Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Osteoarthritis Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 240 Pages
  • Global
From
Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 218 Pages
  • Global
From
Over-The-Counter (OTC) Drug Market 2024-2028 - Product Thumbnail Image

Over-The-Counter (OTC) Drug Market 2024-2028

  • Report
  • September 2024
  • 180 Pages
  • Global
From
Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 94 Pages
  • Global
From
Osteoarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Osteoarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 413 Pages
  • Global
From
Analgesics Global Market Report 2024 - Product Thumbnail Image

Analgesics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Chemotherapy Induced Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 166 Pages
  • Global
From
Diabetic Peripheral Neuropathy (Metabolic Disorder) - Drugs in Development, 2021 - Product Thumbnail Image

Diabetic Peripheral Neuropathy (Metabolic Disorder) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025 - Product Thumbnail Image

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

  • Report
  • August 2018
  • 340 Pages
  • Global
From
Diabetic Peripheral Neuropathy Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Diabetic Peripheral Neuropathy Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 90 Pages
  • Global
From
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2024
  • 96 Pages
  • Global
From
Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 269 Pages
  • Global
From
Migraine - Pipeline Review, H2 2020 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 342 Pages
  • Global
From
  • 13 Results (Page 1 of 1)
Loading Indicator